The NMDA receptor as a target for cognitive enhancement

NMDA receptors (NMDARs) play an important role in neural plasticity including long-term potentiation and long-term depression, which are likely to explain their importance for learning and memory. Cognitive decline is a major problem facing an ageing human population, so much so that its reversal has become an important goal for scientific research and pharmaceutical development. Enhancement of NMDAR function is a core strategy toward this goal. In this review we indicate some of the major ways of potentiating NMDAR function by both direct and indirect modulation. There is good evidence that both positive and negative modulation can enhance function suggesting that a subtle approach correcting imbalances in particular clinical situations will be required. Excessive activation and the resultant deleterious effects will need to be carefully avoided. Finally we describe some novel positive allosteric modulators of NMDARs, with some subunit selectivity, and show initial evidence of their ability to affect NMDAR mediated events. This article is part of a Special Issue entitled 'Cognitive Enhancers'.

[1]  B. Orser,et al.  Metaplasticity gated through differential regulation of GluN2A versus GluN2B receptors by Src family kinases , 2012, The EMBO journal.

[2]  D. Skifter,et al.  A Novel Family of Negative and Positive Allosteric Modulators of NMDA Receptors , 2010, Journal of Pharmacology and Experimental Therapeutics.

[3]  K. Davies,et al.  Phospho-regulation of synaptic and extrasynaptic N-methyl-d-aspartate receptors in adult hippocampal slices , 2009, Neuroscience.

[4]  P. Dutar,et al.  A critical role for the glial‐derived neuromodulator d‐serine in the age‐related deficits of cellular mechanisms of learning and memory , 2006, Aging cell.

[5]  G. Collingridge,et al.  Differential Roles of NR2A and NR2B-Containing NMDA Receptors in Cortical Long-Term Potentiation and Long-Term Depression , 2004, The Journal of Neuroscience.

[6]  R. Dingledine,et al.  Glutamate Receptor Ion Channels: Structure, Regulation, and Function , 2010, Pharmacological Reviews.

[7]  J. Kemp,et al.  Identification of amino acids in the N-methyl-D-aspartate receptor NR1 subunit that contribute to the glycine binding site. , 1995, Molecular pharmacology.

[8]  M. Ehlers Activity level controls postsynaptic composition and signaling via the ubiquitin-proteasome system , 2003, Nature neuroscience.

[9]  E. Molnár Molecular organization and regulation of glutamate receptors in developing and adult mammalian central nervous systems , 2008 .

[10]  Michel Vignes,et al.  Developmental switch from LTD to LTP in low frequency‐induced plasticity , 2006, Hippocampus.

[11]  Chih-Chiang Chiu,et al.  Sarcosine or D-serine add-on treatment for acute exacerbation of schizophrenia: a randomized, double-blind, placebo-controlled study. , 2005, Archives of general psychiatry.

[12]  D. Ferraris,et al.  Recent advances in the discovery of D-amino acid oxidase inhibitors and their therapeutic utility in schizophrenia. , 2011, Current pharmaceutical design.

[13]  S. Oliet,et al.  Long term potentiation depends on release of D-serine from astrocytes , 2009, Nature.

[14]  G. Liao,et al.  Evidence for direct protein kinase-C mediated modulation of N-methyl-D-aspartate receptor current. , 2001, Molecular pharmacology.

[15]  H. Sugiyama,et al.  Allosteric potentiation of quisqualate receptors by a nootropic drug aniracetam. , 1990, The Journal of physiology.

[16]  M. Kennedy,et al.  The major tyrosine-phosphorylated protein in the postsynaptic density fraction is N-methyl-D-aspartate receptor subunit 2B. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[17]  G. Collingridge,et al.  A selective N-methyl-d-aspartate antagonist depresses epileptiform activity in rat hippocampal slices , 1985, Neuroscience Letters.

[18]  L. Vyklický,et al.  Hippocampal neurons exhibit cyclothiazide-sensitive rapidly desensitizing responses to kainate , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[19]  Susumu Tonegawa,et al.  Enhancement of Learning and Memory by Elevating Brain Magnesium , 2010, Neuron.

[20]  S. Heinemann,et al.  Control of proton sensitivity of the NMDA receptor by RNA splicing and polyamines. , 1995, Science.

[21]  T. Robbins,et al.  Selective Remediation of Reversal Learning Deficits in the Neurodevelopmental MAM Model of Schizophrenia by a Novel mGlu5 Positive Allosteric Modulator , 2012, Neuropsychopharmacology.

[22]  L. Nowak,et al.  Magnesium gates glutamate-activated channels in mouse central neurones , 1984, Nature.

[23]  A. Arai,et al.  Pharmacology of ampakine modulators: from AMPA receptors to synapses and behavior. , 2007, Current drug targets.

[24]  A. Foster,et al.  HA-966 antagonizes N-methyl-D-aspartate receptors through a selective interaction with the glycine modulatory site , 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[25]  D. Javitt,et al.  Double-Blind, Placebo-Controlled, Crossover Trial of Glycine Adjuvant Therapy for Treatment-Resistant Schizophrenia , 1996, British Journal of Psychiatry.

[26]  Kai Chang,et al.  The Synaptic Localization of NR2B-Containing NMDA Receptors Is Controlled by Interactions with PDZ Proteins and AP-2 , 2005, Neuron.

[27]  J. Lieberman,et al.  Pregnenolone as a novel therapeutic candidate in schizophrenia: emerging preclinical and clinical evidence , 2011, Neuroscience.

[28]  M. Martina,et al.  Glycine transporter type 1 blockade changes NMDA receptor‐mediated responses and LTP in hippocampal CA1 pyramidal cells by altering extracellular glycine levels , 2004, The Journal of physiology.

[29]  G. Wittenberg,et al.  Acute alcohol blocks neurosteroid modulation of synaptic transmission and long-term potentiation in the rat hippocampal slice , 1995, Brain Research.

[30]  R. Tridgett,et al.  7‐クロルキヌレン酸はN‐メチル‐D‐アスパラギン酸受容体複合体のグリシン調節部位での選択的きっ抗物質である , 1988 .

[31]  Xian-Min Yu,et al.  The regulation of N‐methyl‐d‐aspartate receptors by Src kinase , 2012, The FEBS journal.

[32]  J. Kew,et al.  Allosteric modulators of NR2B‐containing NMDA receptors: molecular mechanisms and therapeutic potential , 2009, British journal of pharmacology.

[33]  G. Collingridge,et al.  Low-frequency activation of the NMDA receptor system can prevent the induction of LTP , 1989, Neuroscience Letters.

[34]  G. Lynch,et al.  A centrally active drug that modulates AMPA receptor gated currents , 1994, Brain Research.

[35]  P. Popik,et al.  Blockade of glycine transporter 1 by SSR-504734 promotes cognitive flexibility in glycine/NMDA receptor-dependent manner , 2011, Neuropharmacology.

[36]  J. Clements,et al.  Adenosine triphosphate acts as both a competitive antagonist and a positive allosteric modulator at recombinant N-methyl-D-aspartate receptors. , 2004, Molecular pharmacology.

[37]  M. Mayer,et al.  Voltage-dependent block by Mg2+ of NMDA responses in spinal cord neurones , 1984, Nature.

[38]  E. Baulieu,et al.  Pregnenolone and its sulfate ester in the rat brain , 1983, Brain Research.

[39]  P. Ascher,et al.  Glycine potentiates the NMDA response in cultured mouse brain neurons , 1987, Nature.

[40]  G. Collingridge,et al.  Activation of the glycine site in the NMDA receptor is necessary for the induction of LTP , 1990, Neuroscience Letters.

[41]  R. Lester,et al.  Synaptic activation of N‐methyl‐D‐aspartate receptors in the Schaffer collateral‐commissural pathway of rat hippocampus. , 1988, The Journal of physiology.

[42]  J. Monahan,et al.  1-Aminocyclobutane-1-carboxylate (ACBC): a specific antagonist of the N-methyl-D-aspartate receptor coupled glycine receptor. , 1989, European journal of pharmacology.

[43]  M. Mayer,et al.  Kinetic analysis of antagonist action at N-methyl-D-aspartic acid receptors. Two binding sites each for glutamate and glycine. , 1991, Biophysical journal.

[44]  G Lynch,et al.  Facilitation of glutamate receptors enhances memory. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[45]  M. Sheng,et al.  Regulation of NMDA receptors by an associated phosphatase-kinase signaling complex. , 1999, Science.

[46]  C. Thornton,et al.  Mind Bomb-2 Is an E3 Ligase That Ubiquitinates the N-Methyl-d-aspartate Receptor NR2B Subunit in a Phosphorylation-dependent Manner* , 2008, Journal of Biological Chemistry.

[47]  L. Danober,et al.  Ring-fused thiadiazines as core structures for the development of potent AMPA receptor potentiators. , 2010, Current medicinal chemistry.

[48]  R. Huganir,et al.  Dual Palmitoylation of NR2 Subunits Regulates NMDA Receptor Trafficking , 2009, Neuron.

[49]  M. Foster Olive,et al.  mGluR5 positive allosteric modulators facilitate both hippocampal LTP and LTD and enhance spatial learning , 2009, Neuropsychopharmacology.

[50]  G. Collingridge,et al.  Carbachol can potentiate N-methyl-d-aspartate responses in the rat hippocampus by a staurosporine and thapsigargin-insensitive mechanism , 1993, Neuroscience Letters.

[51]  E. J. Fletcher,et al.  Glycine reverses antagonism of N-methyl-D-aspartate (NMDA) by 1-hydroxy-3-aminopyrrolidone-2 (HA-966) but not by D-2-amino-5-phosphonovalerate (D-AP5) on rat cortical slices. , 1988, European journal of pharmacology.

[52]  D. Manahan‐Vaughan,et al.  The metabotropic glutamate receptor, mGluR5, is a key determinant of good and bad spatial learning performance and hippocampal synaptic plasticity. , 2005, Cerebral cortex.

[53]  F. Liu,et al.  ADX47273 [S-(4-Fluoro-phenyl)-{3-[3-(4-fluoro-phenyl)-[1,2,4]-oxadiazol-5-yl]-piperidin-1-yl}-methanone]: A Novel Metabotropic Glutamate Receptor 5-Selective Positive Allosteric Modulator with Preclinical Antipsychotic-Like and Procognitive Activities , 2008, Journal of Pharmacology and Experimental Therapeutics.

[54]  C. Jamieson,et al.  Recent advances in positive allosteric modulators of the AMPA receptor. , 2006, Current opinion in drug discovery & development.

[55]  V. Felipo,et al.  Serines 890 and 896 of the NMDA receptor subunit NR1 are differentially phosphorylated by protein kinase C isoforms , 2005, Neurochemistry International.

[56]  P. Sham,et al.  Genetic and physiological data implicating the new human gene G72 and the gene for d-amino acid oxidase in schizophrenia , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[57]  B. Meldrum,et al.  Anticonvulsant action of excitatory amino acid antagonists. , 1982, Science.

[58]  K. Williams Mechanisms influencing stimulatory effects of spermine at recombinant N-methyl-D-aspartate receptors. , 1994, Molecular pharmacology.

[59]  H. Wigström,et al.  Single high strength afferent volleys can produce long-term potentiation in the hippocampus in vitro , 1986, Neuroscience Letters.

[60]  C. Bergman,et al.  Control of NMDA Receptor Activation by a Glycine Transporter Co-Expressed in Xenopus Oocytes , 1997, The Journal of Neuroscience.

[61]  Karla K Kopec,et al.  Glycine transporter (GlyT1) inhibitors with reduced residence time increase prepulse inhibition without inducing hyperlocomotion in DBA/2 mice. , 2010, Biochemical pharmacology.

[62]  D. Lodge,et al.  Evidence for involvement ofN-methylaspartate receptors in ‘wind-up’ of class 2 neurones in the dorsal horn of the rat , 1987, Brain Research.

[63]  J. Coyle,et al.  Modulation of N-methyl-D-aspartate receptor function by glycine transport. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[64]  K. Neve,et al.  Modulation of D2R-NR2B Interactions in Response to Cocaine , 2006, Neuron.

[65]  D. Coulter,et al.  Specific proteolysis of the NR2 subunit at multiple sites by calpain , 2001, Journal of neurochemistry.

[66]  W. Sieghart Multiplicity of GABAA--benzodiazepine receptors. , 1989, Trends in pharmacological sciences.

[67]  G. Lynch,et al.  Activation of the glycine site associated with the NMDA receptor is required for induction of LTP in neonatal hippocampus , 1990, International Journal of Developmental Neuroscience.

[68]  S. Oliet,et al.  Glial D-serine gates NMDA receptors at excitatory synapses in prefrontal cortex. , 2012, Cerebral cortex.

[69]  M. Ehlers,et al.  Coordinated PKA and PKC phosphorylation suppresses RXR-mediated ER retention and regulates the surface delivery of NMDA receptors , 2003, Neuropharmacology.

[70]  H. Simon,et al.  Infusion of neurosteroids into the nucleus basalis magnocellularis affects cognitive processes in the rat , 1993, Brain Research.

[71]  R. Huganir,et al.  Regulated subcellular distribution of the NR1 subunit of the NMDA receptor. , 1995, Science.

[72]  M. Sokabe,et al.  Modulatory metaplasticity induced by pregnenolone sulfate in the rat hippocampus: A leftward shift in LTP/LTD‐frequency curve , 2009, Hippocampus.

[73]  R. H. Evans,et al.  Selective depression of excitatory amino acid induced depolarizations by magnesium ions in isolated spinal cord preparations. , 1980, The Journal of physiology.

[74]  P. Conn,et al.  Metabotropic glutamate receptors as therapeutic targets for schizophrenia , 2012, Neuropharmacology.

[75]  R. Huganir,et al.  Differential Tyrosine Phosphorylation of N-Methyl-D-aspartate Receptor Subunits (*) , 1995, The Journal of Biological Chemistry.

[76]  B. Dubrovsky Steroids, neuroactive steroids and neurosteroids in psychopathology , 2005, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[77]  M. Ehlers,et al.  Ubiquitination in postsynaptic function and plasticity. , 2010, Annual review of cell and developmental biology.

[78]  L. Raymond,et al.  Differential regulation of synaptic and extra-synaptic NMDA receptors , 2002, Nature Neuroscience.

[79]  M. Mayer,et al.  AMPA Receptor Flip/Flop Mutants Affecting Deactivation, Desensitization, and Modulation by Cyclothiazide, Aniracetam, and Thiocyanate , 1996, The Journal of Neuroscience.

[80]  B. Meldrum,et al.  Blockade of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain. , 1984, Science.

[81]  W. Wörner,et al.  Stimulation parameters determine role of GABAB receptors in long-term potentiation , 1993, Experientia.

[82]  M. Lacey,et al.  Electrophysiological characterization of potent agonists and antagonists at pre‐ and postsynaptic GABAB receptors on neurones in rat brain slices , 1990, British journal of pharmacology.

[83]  M. Sheng,et al.  Role of NMDA Receptor Subtypes in Governing the Direction of Hippocampal Synaptic Plasticity , 2004, Science.

[84]  M. Sokabe,et al.  Chronic DHEAS administration facilitates hippocampal long-term potentiation via an amplification of Src-dependent NMDA receptor signaling , 2006, Neuropharmacology.

[85]  P. Ascher,et al.  Glycine uptake governs glycine site occupancy at NMDA receptors of excitatory synapses. , 1998, Journal of neurophysiology.

[86]  L. Langeberg,et al.  Coordination of Three Signaling Enzymes by AKAP79, a Mammalian Scaffold Protein , 1996, Science.

[87]  M. O'Neill,et al.  AMPA receptor potentiators as cognitive enhancers. , 2007, IDrugs : the investigational drugs journal.

[88]  A. Thomson,et al.  Glycine enhances NMDA-receptor mediated synaptic potentials in neocortical slices , 1989, Nature.

[89]  G. Lynch,et al.  The likelihood of cognitive enhancement , 2011, Pharmacology Biochemistry and Behavior.

[90]  C. Davies,et al.  Regulation of EPSPs by the synaptic activation of GABAB autoreceptors in rat hippocampus. , 1996, The Journal of physiology.

[91]  H. Selye Anesthetic Effect of Steroid Hormones.∗ , 1941 .

[92]  B. Moghaddam,et al.  Interaction of N-methyl-D-aspartate and group 5 metabotropic glutamate receptors on behavioral flexibility using a novel operant set-shift paradigm. , 2008, Behavioural pharmacology.

[93]  J. Roder,et al.  D-Serine Augments NMDA-NR2B Receptor-Dependent Hippocampal Long-Term Depression and Spatial Reversal Learning , 2008, Neuropsychopharmacology.

[94]  Robert F. Miller,et al.  Glycine transport accounts for the differential role of glycine vs. d‐serine at NMDA receptor coagonist sites in the salamander retina , 2010, The European journal of neuroscience.

[95]  Nicholas Lange,et al.  Glycine transporter I inhibitor, N-Methylglycine (sarcosine), added to antipsychotics for the treatment of schizophrenia , 2004, Biological Psychiatry.

[96]  Facilitation of Long-Term Potentiation by Muscarinic M1 Receptors Is Mediated by Inhibition of SK Channels , 2010, Neuron.

[97]  R. Purdy,et al.  Distinct sites for inverse modulation of N-methyl-D-aspartate receptors by sulfated steroids. , 1997, Molecular pharmacology.

[98]  E. Gouaux,et al.  Subunit arrangement and function in NMDA receptors , 2005, Nature.

[99]  G. Collingridge Long term potentiation in the hippocampus: mechanisms of initiation and modulation by neurotransmitters , 1985 .

[100]  A. Stuchlik,et al.  The difference in effect of mGlu2/3 and mGlu5 receptor agonists on cognitive impairment induced by MK-801. , 2010, European journal of pharmacology.

[101]  M. Schumacher,et al.  Pregnenolone sulfate enhances long‐term potentiation in CA1 in rat hippocampus slices through the modulation of N‐methyl‐D‐aspartate receptors , 2004, Journal of neuroscience research.

[102]  G. Lynch,et al.  Patterned stimulation at the theta frequency is optimal for the induction of hippocampal long-term potentiation , 1986, Brain Research.

[103]  M. Le Moal,et al.  Neurosteroids: deficient cognitive performance in aged rats depends on low pregnenolone sulfate levels in the hippocampus. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[104]  J. Morley,et al.  Pregnenolone sulfate enhances post-training memory processes when injected in very low doses into limbic system structures: the amygdala is by far the most sensitive. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[105]  K. A. Yamada,et al.  Diazoxide blocks glutamate desensitization and prolongs excitatory postsynaptic currents in rat hippocampal neurons. , 1992, The Journal of physiology.

[106]  G. Collingridge,et al.  The regulation of hippocampal LTP by the molecular switch, a form of metaplasticity, requires mGlu5 receptors , 2005, Neuropharmacology.

[107]  F. Nyberg,et al.  Chronic administration of the anabolic androgenic steroid nandrolone alters neurosteroid action at the sigma-1 receptor but not at the sigma-2 or NMDA receptors , 2011, Neuropharmacology.

[108]  Christopher J. Fox,et al.  Contribution of NR2A and NR2B NMDA subunits to bidirectional synaptic plasticity in the hippocampus in vivo , 2006, Hippocampus.

[109]  C. Davies,et al.  The physiological regulation of synaptic inhibition by GABAB autoreceptors in rat hippocampus. , 1993, The Journal of physiology.

[110]  K. Williams Interactions of polyamines with ion channels. , 1997, The Biochemical journal.

[111]  Hiroto Takahashi,et al.  Excitatory glycine receptors containing the NR3 family of NMDA receptor subunits , 2002, Nature.

[112]  R. Huganir,et al.  Targeting of PKA to Glutamate Receptors through a MAGUK-AKAP Complex , 2000, Neuron.

[113]  N. Hirokawa,et al.  KIF17 Dynamics and Regulation of NR2B Trafficking in Hippocampal Neurons , 2003, The Journal of Neuroscience.

[114]  G. Collingridge,et al.  Muscarinic receptors induce LTD of NMDAR EPSCs via a mechanism involving hippocalcin, AP2 and PSD-95 , 2010, Nature Neuroscience.

[115]  L. Vyklický,et al.  Pregnenolone sulfate modulation of N-methyl-d-aspartate receptors is phosphorylation dependent , 2009, Neuroscience.

[116]  D. Lodge,et al.  Cyclothiazide reverses AMPA receptor antagonism of the 2,3-benzodiazepine, GYKI 53655. , 1993, European journal of pharmacology.

[117]  D. Farb,et al.  Pregnenolone sulfate: a positive allosteric modulator at the N-methyl-D-aspartate receptor. , 1991, Molecular pharmacology.

[118]  R. Nicoll,et al.  Local and diffuse synaptic actions of GABA in the hippocampus , 1993, Neuron.

[119]  Rafael Yuste,et al.  Protein kinase A regulates calcium permeability of NMDA receptors , 2006, Nature Neuroscience.

[120]  J. Widholm,et al.  Glutamatergic Targets for Enhancing Extinction Learning in Drug Addiction , 2010, Current neuropharmacology.

[121]  M. Maekawa,et al.  Spatial learning and long-term potentiation of mutant mice lacking d-amino-acid oxidase , 2005, Neuroscience Research.

[122]  Martin Sarter,et al.  Choline transporters, cholinergic transmission and cognition , 2005, Nature Reviews Neuroscience.

[123]  G. Lynch,et al.  Centrally active modulators of glutamate receptors facilitate the induction of long-term potentiation in vivo. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[124]  K. Roche,et al.  Molecular determinants of NMDA receptor internalization , 2001, Nature Neuroscience.

[125]  M. Bowlby Pregnenolone sulfate potentiation of N-methyl-D-aspartate receptor channels in hippocampal neurons. , 1993, Molecular pharmacology.

[126]  G. Collingridge,et al.  GABAB autoreceptors regulate the induction of LTP , 1991, Nature.

[127]  T. Matozaki,et al.  Src family kinases: modulators of neurotransmitter receptor function and behavior , 2011, Trends in Neurosciences.

[128]  H. Markram,et al.  Acetylcholine potentiates responses to N-methyl-d-aspartate in the rat hippocampus , 1990, Neuroscience Letters.

[129]  G. Collingridge,et al.  Effects of memantine on recombinant rat NMDA receptors expressed in HEK 293 cells , 1996, British journal of pharmacology.

[130]  J. Macdonald,et al.  Regulation of NMDA receptors by the tyrosine kinase Fyn , 2012, The FEBS journal.

[131]  J. D. Clements,et al.  Activation kinetics reveal the number of glutamate and glycine binding sites on the N-methyl-d-aspartate receptor , 1991, Neuron.

[132]  Ryan S. Roark,et al.  Neurosteroid binding to the amino terminal and glutamate binding domains of ionotropic glutamate receptors , 2012, Steroids.

[133]  Yan Hua Huang,et al.  Regulation of the NMDA Receptor Complex and Trafficking by Activity-Dependent Phosphorylation of the NR2B Subunit PDZ Ligand , 2004, The Journal of Neuroscience.

[134]  G. Collingridge,et al.  The use of the hippocampal slice preparation in the study of Alzheimer's disease. , 2008, European journal of pharmacology.

[135]  D. Manahan‐Vaughan,et al.  Rescue of hippocampal LTP and learning deficits in a rat model of psychosis by inhibition of glycine transporter‐1 (GlyT1) , 2008, The European journal of neuroscience.

[136]  M. Salter,et al.  NMDA receptor regulation by Src kinase signalling in excitatory synaptic transmission and plasticity , 2001, Current Opinion in Neurobiology.

[137]  Mark Farrant,et al.  NMDA receptor subunits: diversity, development and disease , 2001, Current Opinion in Neurobiology.

[138]  T. Dunwiddie,et al.  Characteristics of hippocampal primed burst potentiation in vitro and in the awake rat , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[139]  Charles R. Yang,et al.  Glycine tranporter-1 blockade potentiates NMDA-mediated responses in rat prefrontal cortical neurons in vitro and in vivo. , 2003, Journal of neurophysiology.

[140]  G. Collingridge,et al.  Activation of group I mG1uRs potentiates NMDA responses in rat hippocampal slices , 1996, Neuroscience Letters.

[141]  L. Raymond,et al.  Developmental Decrease in NMDA Receptor Desensitization Associated with Shift to Synapse and Interaction with Postsynaptic Density-95 , 2003, The Journal of Neuroscience.

[142]  Yongxiang Zhang,et al.  d-Serine enhances impaired long-term potentiation in CA1 subfield of hippocampal slices from aged senescence-accelerated mouse prone/8 , 2005, Neuroscience Letters.

[143]  Shoji Komai,et al.  Characterization of Fyn-mediated Tyrosine Phosphorylation Sites on GluRε2 (NR2B) Subunit of theN-Methyl-d-aspartate Receptor* , 2001, The Journal of Biological Chemistry.

[144]  H. Eichenbaum,et al.  Serine racemase deletion disrupts memory for order and alters cortical dendritic morphology , 2011, Genes, brain, and behavior.

[145]  L. Vyklický,et al.  Molecular Mechanism of Pregnenolone Sulfate Action at NR1/NR2B Receptors , 2004, The Journal of Neuroscience.

[146]  M. Sokabe,et al.  Continuous de novo synthesis of neurosteroids is required for normal synaptic transmission and plasticity in the dentate gyrus of the rat hippocampus , 2012, Neuropharmacology.

[147]  H. Saito,et al.  Effects of glycine and structurally related amino acids on generation of long-term potentiation in rat hippocampal slices. , 1992, European journal of pharmacology.

[148]  K. Mikoshiba,et al.  Phosphorylation-dependent Regulation ofN-Methyl-d-aspartate Receptors by Calmodulin* , 1997, The Journal of Biological Chemistry.

[149]  G. Lynch,et al.  Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5 , 1986, Nature.

[150]  G. Collingridge,et al.  Coumarin-3-carboxylic acid derivatives as potentiators and inhibitors of recombinant and native N-methyl-d-aspartate receptors , 2012, Neurochemistry International.

[151]  G. Westbrook,et al.  A use-dependent tyrosine dephosphorylation of NMDA receptors is independent of ion flux , 2001, Nature Neuroscience.

[152]  S. Chaki,et al.  d-Serine and a glycine transporter-1 inhibitor enhance social memory in rats , 2010, Psychopharmacology.

[153]  L. Vyklický,et al.  Neurosteroid modulation of N-methyl-d-aspartate receptors: Molecular mechanism and behavioral effects , 2011, Steroids.

[154]  R. V. Omkumar,et al.  Identification of a Phosphorylation Site for Calcium/Calmodulindependent Protein Kinase II in the NR2B Subunit of the N-Methyl-D-aspartate Receptor* , 1996, The Journal of Biological Chemistry.

[155]  J. Hell,et al.  Cyclic AMP-dependent Protein Kinase and Protein Kinase C Phosphorylate N-Methyl-d-aspartate Receptors at Different Sites* , 1997, The Journal of Biological Chemistry.

[156]  R. Neumar,et al.  Selective Activation Induced Cleavage of the NR2B Subunit by Calpain , 2003, The Journal of Neuroscience.

[157]  R. Dingledine,et al.  Requirement for glycine in activation of NMDA-receptors expressed in Xenopus oocytes. , 1988, Science.

[158]  R. Dingledine,et al.  Involvement of N-methyl-d-aspartate Receptors in Involvement of N-methyl-d-aspartate Receptors in Epileptiform Bursting in the Rat Hippocampal Slice , 2008 .

[159]  A. Ganong,et al.  Modulation of NMDA receptor function by inhibition of d-amino acid oxidase in rodent brain , 2011, Neuropharmacology.

[160]  Nicholas Lange,et al.  D-serine added to antipsychotics for the treatment of schizophrenia , 1998, Biological Psychiatry.

[161]  M. Poo,et al.  Contribution of astrocytes to hippocampal long-term potentiation through release of d-serine , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[162]  S N Davies,et al.  Paired‐pulse depression of monosynaptic GABA‐mediated inhibitory postsynaptic responses in rat hippocampus. , 1990, The Journal of physiology.

[163]  C. McKerlie,et al.  Neto1 Is a Novel CUB-Domain NMDA Receptor–Interacting Protein Required for Synaptic Plasticity and Learning , 2009, PLoS biology.

[164]  S. Ward,et al.  Recent advances in the discovery of selective AMPA receptor positive allosteric modulators. , 2010, Current medicinal chemistry.

[165]  J. Isaac,et al.  Casein Kinase 2 Regulates the NR2 Subunit Composition of Synaptic NMDA Receptors , 2010, Neuron.

[166]  P. Lombroso,et al.  Striatal Enriched Phosphatase 61 Dephosphorylates Fyn at Phosphotyrosine 420* , 2002, The Journal of Biological Chemistry.

[167]  M P Walsh,et al.  Regulation of NMDA Receptor Activity by F-Actin and Myosin Light Chain Kinase , 2001, The Journal of Neuroscience.

[168]  Mark F Bear,et al.  The ratio of NR2A/B NMDA receptor subunits determines the qualities of ocular dominance plasticity in visual cortex , 2009, Proceedings of the National Academy of Sciences.

[169]  C. Parsons,et al.  The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer's disease: preclinical evidence , 2003, International journal of geriatric psychiatry.

[170]  R. Huganir,et al.  Inactivation of NMDA Receptors by Direct Interaction of Calmodulin with the NR1 Subunit , 1996, Cell.

[171]  G. Collingridge,et al.  Excitatory amino acids in synaptic transmission in the Schaffer collateral‐commissural pathway of the rat hippocampus. , 1983, The Journal of physiology.

[172]  K. Williams Subunit-specific potentiation of recombinant N-methyl-D-aspartate receptors by histamine. , 1994, Molecular pharmacology.

[173]  S. Russek,et al.  A steroid modulatory domain on NR2B controls N-methyl-D-aspartate receptor proton sensitivity. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[174]  H. Rosenbrock,et al.  Differential effect of the mGlu5 receptor positive allosteric modulator ADX-47273 on early and late hippocampal LTP , 2011, Neuropharmacology.

[175]  J. Uslaner,et al.  The Therapeutic Potential of D-Amino Acid Oxidase (DAAO) Inhibitors , 2010, The open medicinal chemistry journal.

[176]  P. Greengard,et al.  Regulation of NMDA receptor trafficking by amyloid-β , 2005, Nature Neuroscience.

[177]  G. Collingridge,et al.  CGP 55845A: A potent antagonist of GABAb receptors in the CA1 region of rat hippocampus , 1993, Neuropharmacology.

[178]  J. Morley,et al.  Memory-enhancing effects in male mice of pregnenolone and steroids metabolically derived from it. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[179]  D. Gruol,et al.  Steroid pregnenolone sulfate enhances NMDA‐receptor‐independent long‐term potentiation at hippocampal CA1 synapses: Role for L‐type calcium channels and sigma‐receptors , 2007, Hippocampus.

[180]  D. Liotta,et al.  A subunit-selective potentiator of NR2C- and NR2D-containing NMDA receptors. , 2010, Nature communications.

[181]  G. Collingridge,et al.  (RS)-2-Chloro-5-Hydroxyphenylglycine (CHPG) Activates mGlu5, but not mGlu1, Receptors Expressed in CHO Cells and Potentiates NMDA Responses in the Hippocampus , 1997, Neuropharmacology.

[182]  G. Collingridge,et al.  Frequency-dependent involvement of NMDA receptors in the hippocampus: a novel synaptic mechanism , 1986, Nature.

[183]  J. Leonard,et al.  Identification of mouse NMDA receptor subunit NR2A C‐terminal tyrosine sites phosphorylated by coexpression with v‐Src , 2001, Journal of neurochemistry.

[184]  H. Betz,et al.  The N-Terminal Domains of both NR1 and NR2 Subunits Determine Allosteric Zn2+ Inhibition and Glycine Affinity of N-Methyl-d-aspartate Receptors , 2007, Molecular Pharmacology.

[185]  D. Lynch,et al.  Calpain and the glutamatergic synapse. , 2009, Frontiers in bioscience.

[186]  L. Raymond,et al.  Mechanisms underlying NMDA receptor synaptic/extrasynaptic distribution and function , 2011, Molecular and Cellular Neuroscience.

[187]  D. Coulter,et al.  Developmental and cell‐selective variations in N‐methyl‐d‐aspartate receptor degradation by calpain , 2006, Journal of neurochemistry.

[188]  Rand Askalan,et al.  Tyrosine Phosphatase STEP Is a Tonic Brake on Induction of Long-Term Potentiation , 2002, Neuron.

[189]  M. Sokabe,et al.  PREGS Induces LTP in the Hippocampal Dentate Gyrus of Adult Rats Via the Tyrosine Phosphorylation International Cooperative Research CREB Signaling , 2007 .

[190]  R. Huganir,et al.  Characterization of Protein Kinase A and Protein Kinase C Phosphorylation of the N-Methyl-D-aspartate Receptor NR1 Subunit Using Phosphorylation Site-specific Antibodies* , 1997, The Journal of Biological Chemistry.

[191]  G. Collingridge,et al.  Effects of memantine and MK‐801 on NMDA‐induced currents in cultured neurones and on synaptic transmission and LTP in area CA1 of rat hippocampal slices , 1996, British journal of pharmacology.

[192]  S. Russek,et al.  A steroid modulatory domain in NR2A collaborates with NR1 exon‐5 to control NMDAR modulation by pregnenolone sulfate and protons , 2011, Journal of neurochemistry.

[193]  L. Vyklický,et al.  Subtype-dependence of N-methyl-d-aspartate receptor modulation by pregnenolone sulfate , 2006, Neuroscience.

[194]  S. Kulkarni,et al.  The effects of neurosteroids on acquisition and retention of a modified passive-avoidance learning task in mice , 1998, Brain Research.

[195]  K. Nikolich,et al.  Regulation of NMDA receptor trafficking and function by striatal‐enriched tyrosine phosphatase (STEP) , 2006, The European journal of neuroscience.

[196]  A. Kuryatov,et al.  Mutational analysis of the glycine-binding site of the NMDA receptor: Structural similarity with bacterial amino acid-binding proteins , 1994, Neuron.

[197]  E. Shimizu,et al.  Genetic enhancement of learning and memory in mice , 1999, Nature.

[198]  M. Ehlers,et al.  An NMDA Receptor ER Retention Signal Regulated by Phosphorylation and Alternative Splicing , 2001, The Journal of Neuroscience.

[199]  A. Craig,et al.  Rapid Synaptic Remodeling by Protein Kinase C: Reciprocal Translocation of NMDA Receptors and Calcium/Calmodulin-Dependent Kinase II , 2002, The Journal of Neuroscience.

[200]  C. Parsons,et al.  Memantine restores long term potentiation impaired by tonic N-methyl-d-aspartate (NMDA) receptor activation following reduction of Mg2+ In hippocampal slices , 1999, Neuropharmacology.

[201]  L. Iversen,et al.  7-Chlorokynurenic acid is a selective antagonist at the glycine modulatory site of the N-methyl-D-aspartate receptor complex. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[202]  D. Lodge,et al.  Potentiation of responses to AMPA on central neurones by LY392098 and LY404187 in vivo , 2001, Neuropharmacology.

[203]  A. Craig,et al.  cAMP-Dependent Protein Kinase Mediates Activity-Regulated Synaptic Targeting of NMDA Receptors , 2001, The Journal of Neuroscience.